Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
December 18, 2023
The Lancet Investing in Health Commission, led by Larry Summers and Dean Jamison in 2013, envisioned a grand convergence in key health indicators by 2035 between low-income and low-middle-income countries and the best-performing middle-income countries. Given significant global changes since the rep...
Blog Post
October 30, 2023
Realizing the Sustainable Development Goals (SDGs) and tackling the climate crisis in developing nations demands substantial investments. A recent report commissioned by the G20 estimated that for developing countries (encompassing low-income, lower-middle-income, and upper-middle-income nations), a...
Blog Post
September 21, 2023
The politics of antimicrobial resistance (AMR) has changed substantially since we launched the first CGD working group on AMR in 2007. There is now much more awareness about the need to act, even if global solutions have not yet been implemented. Countries including the UK, Canada, and Japan have an...
REPORTS
September 20, 2023
In our final working group report, we outline the principles of a Grand Bargain that we believe all stakeholders can and should sign up to during the UN General Assembly's High-Level Meeting on antimicrobial resistance in 2024. Explore our recommendations on increasing the availability of critically...
Blog Post
August 30, 2023
Developing Asia as a region has experienced rapid growth over the past three decades. What have these episodes of sustained growth meant for income inequality? Has the region had “inclusive growth,” meaning growth which saw incomes rise without inequality increasing, or has inequality gotten worse? ...
WORKING PAPERS
August 30, 2023
Higher levels of fiscal redistribution, through income taxes and direct transfers, increase the probability of achieving inclusive growth. To spur inclusive growth in the aftermath of the COVID pandemic, countries with limited fiscal space will need to focus on improving efficiency and reallocate ex...
POLICY PAPERS
August 07, 2023
A main driver of antimicrobial resistance is the misuse and overuse of antimicrobials. But lack of access to antimicrobials causes a large mortality burden and contributes to the spread of resistant infections. How can learnings from the use of control policies in other areas of medicine be translat...
Blog Post
August 07, 2023
In a new paper, we argue that the idea of “stewardship”—and the tension between some stewardship policies and patient access—extends well beyond antimicrobials, to all drug classes. We consider the many reasons why governments opt to impose controls on medicines, and how rationales for control relat...
Blog Post
August 02, 2023
The future of such spending in countries currently experiencing or at high risk of debt distress is particularly troubling. A country is in debt distress when its ability to service domestic and external debt is impaired. This blog post delves into these issues based on more recent health spending a...
BRIEFS
July 31, 2023
India is racing against the clock in its fight against antimicrobial resistance. A combination of complex regulatory and procurement systems, a lack of health insurance penetration, and little groundwork on state and national action plans has stymied progress. A multifold approach is needed to impro...